# US 2008/0076127 A1 · Method and compositions for detecting helicobacter pylori

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076127 A1
- Document ID: US20080076127A1
- Status: Published application
- Kind: A1
- Application number: 11/742,111
- Filed: 2007-04-30
- Published: 2008-03-27
- Earliest claimed: 2006-09-26
- Assignees: Samsung Electronics Co., Ltd.
- Inventors: Ji-young OH; Jung-nam LEE
- Web page: https://patentgrep.com/patent/US20080076127A1

## CPC

- C12Q 1/689: for bacteria
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided are an oligonucleotide primer set for amplifying at least one target sequence of the cagA gene of Helicobacter pylori, a method of detecting Helicobacter pylori using the primer set, and a kit for detecting Helicobacter pylori, including the primer set.

## Claims

### Claim 1

An oligonucleotide primer set comprising:
an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 1 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 2;
an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 3 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 4; or
an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 5 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO:6,
wherein the oligonucleotide primer set amplifies a target sequence in a cagA gene of Helicobacter pylori (H. pylori).

### Claim 2 (depends on 1)

The oligonucleotide primer set of claim 1, wherein the target sequence is selected from the group consisting of nucleotide regions corresponding to positions 428-624, 433-668 and 431-671 of SEQ ID NO: 7

### Claim 3 (depends on 1)

The oligonucleotide primer set of claim 1, which comprises an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in the nucleotide sequence as set forth in SEQ ID NO: 1 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in the nucleotide sequence as set forth in SEQ ID NO: 2,
wherein the oligonucleotide primer set amplifies a nucleotide region corresponding to positions 428-624 of SEQ ID NO: 7.

### Claim 4 (depends on 1)

The oligonucleotide primer set of claim 1, which comprises an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in the nucleotide sequence as set forth in SEQ ID NO: 3 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in the nucleotide sequence as set forth in SEQ ID NO: 4,
wherein the oligonucleotide primer set amplifies a nucleotide region corresponding to positions 433-668 of SEQ ID NO: 7.

### Claim 5 (depends on 1)

The oligonucleotide primer set of claim 1, which comprises an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in the nucleotide sequence as set forth in SEQ ID NO: 5 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in the nucleotide sequence as set forth in SEQ ID NO: 6,
wherein the oligonucleotide primer set amplifies a nucleotide region corresponding to positions 431-671 of SEQ ID NO: 7.

### Claim 6 (depends on 1)

The oligonucleotide primer set of claim 1 comprising:
an oligonucleotide set comprising an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 1 and an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 2,
wherein the oligonucleotide set amplifies a target sequence in a cagA gene of H. pylori corresponding to positions 428-624 of SEQ ID NO: 7;
an oligonucleotide set comprising an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 3 and an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 4,
wherein the oligonucleotide set amplifies a target sequence in a cagA gene of H. pylori corresponding to positions 433-668 of SEQ ID NO: 7; and
an oligonucleotide set comprising an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 5 and an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 6,
wherein the oligonucleotide set amplifies a target sequence in a cagA gene of H. pylori corresponding to positions 431-671 of SEQ ID NO: 7.

### Claim 7

A method of detecting H. pylori in a sample, the method comprising:
using genomic DNA as a template and an oligonucleotide primer set specific for amplifying an H. pylori-specific target sequence in an H. pylori cagA gene in an amplification reaction; and
detecting H. pylori in a sample when the H. pylori -specific target sequence is amplified.

### Claim 8 (depends on 7)

The method of claim 7, wherein the oligonucleotide primer set comprises:
an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 1 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 2;
an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 3 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 4; or
an oligonucleotide set comprising an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 5 and an oligonucleotide consisting of at least 10 contiguous nucleotides present in a nucleotide sequence as set forth in SEQ ID NO: 6.

### Claim 9 (depends on 8)

The method of claim 8, wherein the oligonucleotide primer set comprises
an oligonucleotide set comprising an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 1 and an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 2;
an oligonucleotide set comprising an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 3 and an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 4; and
an oligonucleotide set comprising an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 5 and an oligonucleotide consisting of the nucleotide sequence as set forth in SEQ ID NO: 6.

### Claim 10 (depends on 7)

The method of claim 7, wherein the H. pylori-specific target sequence is a nucleotide region of a cagA coding sequence of H. pylori corresponding to positions 428-624, 433-668, or 431-671 of SEQ ID NO: 7.

### Claim 11 (depends on 7)

The method of claim 7, wherein the H. pylori-specific target sequence is a nucleotide region of a cagA gene of H. pylori corresponding to positions 428-624, 433-668, and 431-671 of SEQ ID NO: 7.

### Claim 12 (depends on 7)

The method of claim 7, wherein the oligonucleotide primer set comprises an oligonucleotide set specific for the H. pylori-specific target sequence of a cagA gene corresponding to positions 428-624 of SEQ ID NO: 7, an oligonucleotide set specific for the H. pylori-specific target sequence of the cagA gene corresponding to positions 433-668 of SEQ ID NO: 7, and an oligonucleotide set specific for the H. pylori-specific target sequence of the cagA gene corresponding to positions 431-671 of SEQ ID NO: 7.

### Claim 13 (depends on 7)

The method of claim 7, wherein the amplified H. pylori-specific target sequence is labeled with a detectable labeling material.

### Claim 14 (depends on 13)

The method of claim 13, wherein the labeling material is a fluorescent material, a phosphorescent material, or a radioactive material.

### Claim 15 (depends on 7)

The method of claim 7, wherein detecting H. pylori in the sample when the H. pylori-specific target sequence is amplified is performed using a DNA chip, gel electrophoresis, a radiation measurement, a fluorescence measurement, or a phosphorescence measurement.

### Claim 16 (depends on 7)

The method of claim 7, wherein the amplification reaction is performed using polymerase chain reaction (PCR), ligase chain reaction, nucleic acid sequence-based amplification, transcription-based amplification system, strand displacement amplification, or Qβ replicase amplification.

### Claim 17 (depends on 7)

The method of claim 7, wherein the sample is saliva, a biopsy sample, blood, a skin tissue, a liquid culture, feces, or urine.

### Claim 18 (depends on 1)

A kit for detecting H. pylori in a sample, the kit comprising:
the oligonucleotide primer set of claim 1; and
a reagent for performing amplification of a nucleic acid in a sample.

### Claim 19 (depends on 18)

The kit of claim 18, wherein the reagent comprises DNA polymerase, dNTPs, and a buffer.

### Claim 20 (depends on 18)

The kit of claim 18, wherein the sample is saliva, a biopsy sample, blood, a skin tissue, a liquid culture, feces, or urine.
